Another critical limitation is the absence of control groups, as all evaluated studies were open-label, single-arm trials [100,101,102]
This is the reality for millions living with Long COVID symptoms, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and complex chronic conditions like dysautonomia and mast cell activation syndrome (MCAS)
Vitamin C, hay cn c gi l axit ascorbic, l cht dinh dng m c th cn trong qu trnh hnh thnh mch mu, sn, c v collagen trong xng (2)
doi: 10.1016/S0140-6736(20)32511-3 Summary Keywords chronic liver disorder, metabolic syndrome, non-alcoholic fatty liver disease, oxidative stress, oral glutathione Citation Santacroce G, Gentile A, Soriano S, Novelli A, Lenti MV and Di Sabatino A (2023) Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease